Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."

TSX:MSL - Post Discussion

MERUS LABS INTERNATIONAL INC > The stock price
View:
Post by sicnarf2 on Aug 21, 2015 10:10am

The stock price

Appears to be trickeling down.
Comment by Craigbad on Aug 21, 2015 11:20am
Stop loss recommended at $2.02, probably people hunting it and dangerously close now. Support is listed at $1.65.  13 bearish indicators, one positive but turning down again.  Whole sector getting destroyed, not looking good right now.  
Comment by BearBullBrian on Aug 21, 2015 11:27am
In a correction, sectors with the greatest gains produce the biggest downside. It's a source of profits for many and helps some investors balance out the losers. This activity produces big opportunites for others with cash on hand. BBB
Comment by curiousbuild on Aug 21, 2015 2:36pm
Canaccord steady buyer today, I bought more too.. I assume a lot of retail stop losses and margin calls happened yesterday and today..  CB 
Comment by Craigbad on Aug 21, 2015 4:23pm
Hearing MM's possibly selling poitions to buy shelf prospectus when company is ready to make a purchase as they will buy at or below market price, which makes sense. Strong downtrend in place, best to stay out of the way and let the players play. Once they make a purchase we should see a turnaround.
Comment by Craigbad on Aug 21, 2015 4:33pm
Market is expensive for buying companies right now and Merus is looking to buy at the right price.  It may take some time to find the right purchase, be patient if you're long it could be some time before the right deal comes up. Hopefully by spring things will look up!
Comment by peter75 on Aug 21, 2015 5:26pm
Craigbad with al due respect you are way off base merus has 45 million plus sitting in cash ! The notes are interest bearing at 5 3/r percent there is no way that they will wait six plus months to pull the trigger
Comment by curiousbuild on Aug 21, 2015 5:31pm
What if market price $3.25 let's say.. Not sure I get the logic behind your scenario..  What if there was no sell off on markets this week?  CB 
Comment by Craigbad on Aug 21, 2015 5:46pm
Arguing with indicators has lost me money in the past so i avoid it.  The stock is just off the stop loss of $2.02 and in a weak market it is likely to hit that trigger and test support at $1.65. Technically it should hit at least $1.90, Mm's know this and there is no catalyst to keep holding the stock short term.  Target prices for next year include them making a deal and deals are ...more  
Comment by curiousbuild on Aug 21, 2015 6:56pm
Well there must be 20M+ stop losses at $2.02 then.. %40 retracement in two weeks, I don't say it won't go another %80 down as anything is possible in stock markets..  We will find out how Monday will roll as Chinese markets open on Sunday evening..  GL CB 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities